Disease and poverty fellow Peter J. Hotez, M.D., recently discussed the ethical development of Ebola drugs for the New York Times' "Room for Debate" series. "Controlled trials would be the fastest and most accurate tests and the only proven path to determine vaccine safety and efficacy," Hotez wrote. Read his full commentary, "Controls Are Needed to Test Vaccines, Not All Ebola Drugs," in the Dec. 1, 2014, New York Times.
